Pumas-AI, Inc.
Peter Miller has a comprehensive work experience spanning several decades. Peter is currently the Head of Quality & Compliance at Pumas-AI, Inc. since July 2022. Prior to this role, Peter founded Dynamic Compliance Solutions, Inc. in 2007, where they served as the President, providing Quality and Compliance services to the Life Science industry.
Before founding their company, Peter worked at Bristol-Myers Squibb from May 2001 to May 2007 as the Director Global Shared Services Quality. In this position, they were responsible for Quality Operations, Internal and External Auditing, Document & Change Management, and Computer System Validation. Peter was also accountable for regulatory interpretation and the provision of specialized resources within the division.
Earlier in their career, Peter held the position of Manager QC/QA Systems at BASF – Knoll Pharmaceutical Division from September 1996 to May 2001. There, they provided consultation for FDA compliance issues and designed/implemented the Laboratory Information Management System (LIMS). Prior to that, they served as the Manager Quality Data Management at SmithKline Beecham – Worldwide Supply Organization from November 1991 to September 1996, where they oversaw computerized Quality systems and laboratory automation.
Additionally, Peter started their career as a Quality Assurance Engineer at Datascope, Inc. from September 1988 to November 1991. Throughout their career, Peter Miller has demonstrated expertise in Quality and Compliance within the Life Science industry, holding various managerial and leadership positions.
Peter Miller attended the New Jersey Institute of Technology from 1984 to 1988. During this time, they pursued a Bachelor of Science degree in Biomedical/Medical Engineering.
This person is not in any teams
This person is not in any offices
Pumas-AI, Inc.
Pumas-AI was founded by Dr. Joga Gobburu and Dr. Vijay Ivaturi, driven by a team of scientists at the University of Maryland in partnership with scientific computing experts. The solutions offered at Pumas-AI are fine-tuned to the needs of healthcare research, regulation and delivery, with a central vision to double pharmaceutical and patient caresuccess by democratizing tools and education in the healthcare data analytics space. With a focused goal on providing better solutions for patient care, be it via pharmaceutical drug development innovation or tools for point of care, Pumas-AI aims to bring value, innovation and efficiency to healthcare.Pumas is a one-stop integrated modeling and simulation platform designed to provide analytic capabilities and support high-performance drug development teams where collaboration is key. Developed for drug/biotech development and therapeutic decision making, it leverages the power of the Julia programming language to combine modern AI with traditional mechanistic models to gain massive computational efficiency. With its complete range of analytics capabilities, Pumas gives pharmaceutical/biotech companies and their investors usable quantitative metrics on technical, regulatory, and commercial success probabilities. Pumas was developed as a cloud-first technology that allows scientists scale to thousands of CPUs and GPUs with a single click. The software is free for non-commercial research and training.